Clinical trial Recruiting at 1 site Observational Ages 18 to 75 Women only

New method for detecting MicroRNA in breast cancer patients

Official title: A New Detection Method for MicroRNA in Patients With Breast Cancer

Run by Tongji Hospital · NCT06529614 · Data updated 2026-11-12

This study is testing a new way to detect MicroRNA in the blood of breast cancer patients to see if it can help track the disease and how well treatments are working.

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexWomen only
Enrollment100 (estimated)
SponsorTongji Hospital
Academic / other
Locations1 site (Wuhan, Hubei)
StatusRecruiting
StartedJuly 20, 2024
Main results expectedSeptember 1, 2025
Study endsNovember 1, 2025
Registry record updatedOctober 6, 2025
Trial IDNCT06529614 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients diagnosed with breast cancer who are healthy otherwise and do not have serious comorbidities.

Probably not a fit

Patients with serious diseases or conditions that may interfere with the results of the MicroRNA detection will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on developing a novel in-situ detection method for MicroRNA in the serum of patients diagnosed with breast cancer. The approach aims to improve the accuracy of MicroRNA detection, which could enhance the understanding of breast cancer progression and treatment response. By analyzing serum samples, the study seeks to establish a reliable biomarker for monitoring the disease. The methodology involves collecting serum samples from participants and applying the new detection technique to assess MicroRNA levels.

Why it matters

Potential benefit: If successful, this method could provide a more accurate and non-invasive way to monitor breast cancer progression and treatment efficacy.

How similar studies have gone: While there have been studies exploring MicroRNA detection in cancer, this specific in-situ detection method is novel and has not been widely tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: Healthy without serious diseases

\-

Exclusion Criteria:

* situations that may affect the results

Where it's running

  • Tongji Hospital
    Wuhan, Hubei, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.